Prominent collagen type VI expression in juvenile angiofibromas.
The extracellular matrix component collagen type VI demonstrates potent growth-stimulatory effects and has been associated with aggressive tumour growth. Although, juvenile angiofibromas (JAs) often exhibit an aggressive growth pattern, the collagen type VI expression of this fibrovascular tumour has not been addressed so far. RT-PCR, Western blot analysis and immunohistochemistry were used in this study to analyse collagen type VI, type VI collagen receptor subunits (integrin alpha1, alpha2, alpha10, alpha11 and beta1) and the type VI collagen receptor NG2 in JAs (N = 15) and nasal mucosa (NM, N = 8) samples. The mRNA expression of all three collagen type VI chains was found to be up-regulated significantly (P < 10(-3)-10(-5), adjusted) in JAs compared to NM tissues. The Western blot analysis proved highly prominent collagen-type VI expression in JAs. The ApoTome technique revealed strong collagen-type VI signals in tumour endothelium. NG2 (P < 10(-3), adjusted) and alpha11-integrin (P = 0.04, adjusted) showed a significantly higher mRNA expression levels in JAs than in NM samples. NG2, alpha1-, alpha2- and beta1-intergin were located to tumour vessels, and additional stromal signals were observed for NG2 and alpha1-integrin in JAs. This study demonstrates a prominent collagen-type VI expression in JAs. The collagen-type VI may exert an important growth stimulus in this tumour.
Gramann
Monika
M
Department of Otolaryngology, Head- and Neck Surgery, University Erlangen-Nuremberg, Erlangen, Germany. monika.gramann@uk-erlangen.de
Wendler
Olaf
O
Haeberle
Lothar
L
Schick
Bernhard
B
D000293:Adolescent; D000328:Adult; D018322:Angiofibroma / Q000378:metabolism*; D024142:Collagen Type VI / Q000235:genetics / Q000378:metabolism*; D005109:Extracellular Matrix / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D006801:Humans; D008297:Male
D024142:Collagen Type VI
Matrix Biol. 2000 Aug;19(4):319-23
10963992
Int J Biochem Cell Biol. 2004 Aug;36(8):1405-10
15147720
Int J Cancer. 2006 Feb 15;118(4):889-98
16152594
Anal Biochem. 1985 Aug 15;149(1):238-47
4073480
Am J Pathol. 2001 Mar;158(3):1073-8
11238055
Cancer Res. 2004 Feb 1;64(3):817-20
14871805
Cells Tissues Organs. 2009;189(6):403-9
18815441
Cell Tissue Res. 2006 Aug;325(2):315-24
16568302
Cancer Cell. 2003 Apr;3(4):377-86
12726863
Differentiation. 2007 Jun;75(5):463-77
17286603
Exp Cell Res. 1993 Nov;209(1):103-17
8223995
Matrix Biol. 2007 Apr;26(3):146-55
17141492
Mol Cell Biol. 2008 Jan;28(2):794-802
17984225
J Clin Invest. 2005 May;115(5):1163-76
15841211
J Biol Chem. 2006 Jun 16;281(24):16607-14
16613849
Exp Cell Res. 1998 May 25;241(1):230-41
9633532
J Cell Physiol. 1998 Nov;177(2):299-312
9766527
Melanoma Res. 2007 Aug;17(4):215-23
17625451
J Am Soc Nephrol. 1999 Apr;10(4):779-89
10203362
J Biol Chem. 1999 Nov 26;274(48):34361-8
10567413
Mol Med. 2007 Mar-Apr;13(3-4):160-5
17592550
Acta Radiol. 2000 Nov;41(6):585-93
11092480
Brain Cell Biol. 2006 Jun;35(2-3):159-72
17957481
Microsc Res Tech. 2003 Jan 1;60(1):13-22
12500256
Eur Arch Otorhinolaryngol. 2007 Jul;264(7):769-75
17310347
Cancer Genet Cytogenet. 2006 Jan 1;164(1):25-31
16364759
Hum Pathol. 2008 Feb;39(2):259-68
17950779
Laryngoscope. 1989 Apr;99(4):429-37
2538688
Mol Biol Cell. 1999 Oct;10(10):3373-87
10512873
Biochem J. 1990 Dec 15;272(3):787-95
1702626
Hosp Med. 2004 May;65(5):269-73
15176142